Market News (Page 12) - TendieTensor

Market News Page 12 of 278 • 6,939 articles

UTStarcom Launches SkyFlux SPN310 to Empower Enterprise and Metro Edge Networks

GlobeNewswire Inc. • Utstarcom Holdings Corp.

UTStarcom Launches SkyFlux SPN310 to Empower Enterprise and Metro Edge Networks

01/08/2026 03:36 AM • UTStarcom announced the launch of the SkyFlux SPN310, a compact and cost-effective router designed for metro access and enterprise edge applications. The device features 16Gbps switching capacity, multiple interface options, and a fanless design. The company is also releasing a firmware version compatible with its NG-PTN NetRing platform to expand market reach.

VYLD - Participating as lead bank in the bridge loan syndicate without significant additional context
UTSI - The company is expanding its product portfolio with a new cost-effective solution targeting growing enterprise and metro network markets. The dual firmware strategy demonstrates innovation and market expansion efforts, positioning the company to serve a wider customer base while maintaining cost efficiency.

#SkyFlux SPN310 #router #metro access #enterprise edge #packet transport #5G backhaul #broadband aggregation #cost-effective

GlobeNewswire Inc. • Na

Form 8.5 (EPT/RI)-Dowlais Group plc

01/08/2026 03:35 AM • Investec Bank plc, acting as broker to Dowlais Group Plc, disclosed public dealing in Dowlais Group ordinary shares on January 7, 2026. The exempt principal trader purchased 95,325 shares at prices between 86.88 and 88.48 per unit, and sold 50,000 shares at 86.8 per unit.

CRARY - Participating bank in the loan syndicate without significant additional context
IVTJY - Investec is acting in a broker capacity and making routine regulatory disclosures. The dealing activity itself is neutral market-making activity with no indication of positive or negative developments.

#Investec Bank plc #Dowlais Group Plc #share dealing #takeover code disclosure #exempt principal trader #ordinary shares

LMT Stock Whipsaws After Trump Bans Buybacks, Then Calls For $1.5 Trillion Military Budget

Benzinga • Vishaal Sanjay

LMT Stock Whipsaws After Trump Bans Buybacks, Then Calls For $1.5 Trillion Military Budget

01/08/2026 02:52 AM • Lockheed Martin stock experienced significant volatility on Tuesday after President Trump criticized defense contractors' dividends and buybacks, causing a 4.82% decline. However, the stock recovered with a 6.3% overnight gain following Trump's subsequent announcement of a proposed $1.5 trillion military budget for 2027, up from $1 trillion.

JPMpK - Participating as lead bank in the bridge loan syndicate without significant additional context
LMT - Mixed signals with initial negative pressure from buyback ban (-4.82%) offset by positive outlook from increased military budget proposal (+6.3% overnight). Long-term impact remains uncertain pending policy implementation.

#defense contractors #stock buybacks #dividends #military budget #executive compensation #stock volatility

ISIN DK0030484621 - FRN Tryg Forsikring A/S Subordinated Callable SEK 1,000,000,000 Bond Issue (the

GlobeNewswire Inc. • Na

ISIN DK0030484621 - FRN Tryg Forsikring A/S Subordinated Callable SEK 1,000,000,000 Bond Issue (the "Bonds") - Exercise of Ordinary Call - Key information

01/08/2026 02:37 AM • Tryg Forsikring A/S has exercised an ordinary call on its perpetual subordinated callable SEK 1 billion bond (ISIN DK0030484621), with settlement scheduled for 26 February 2026 at a price of SEK 1,011,106.44 per SEK 1,000,000 nominal amount plus accrued interest. Following settlement, all outstanding bonds will be redeemed.

JPMpL - Participating as lead bank in the bridge loan syndicate without significant additional context
TGVSY - The exercise of a callable bond is a routine capital management action. The issuer is redeeming debt at par plus accrued interest, which is a standard financial operation. There is no indication of financial distress or positive developments; this is a normal refinancing activity.

#bond redemption #callable bond #subordinated debt #Tier 1 capital #ordinary call #perpetual bond

Sprouts Farmers Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Sprouts Farmers Market, Inc. - SFM

GlobeNewswire Inc. • Claimsfiler

Sprouts Farmers Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Sprouts Farmers Market, Inc. - SFM

01/07/2026 10:56 PM • Sprouts Farmers Market faces a securities class action lawsuit for failing to disclose material information during June-October 2025. The company's stock plummeted 26.11% on October 30, 2025, following disappointing Q3 results and reduced guidance. Investors with losses exceeding $100,000 must file lead plaintiff applications by January 26, 2026.

BNPZY - Participating as part of the banking pool in a standard loan syndication
SFM - The company is facing securities litigation for alleged failure to disclose material information. Stock experienced a severe 26.11% single-day decline following disappointing Q3 earnings and reduced full-year guidance, indicating significant investor losses and loss of confidence in management's prior guidance.

#class action lawsuit #securities fraud #material non-disclosure #stock decline #disappointing earnings #lead plaintiff deadline

Alumis Announces Pricing of Upsized Public Offering of Common Stock

GlobeNewswire Inc. • Na

Alumis Announces Pricing of Upsized Public Offering of Common Stock

01/07/2026 10:52 PM • Alumis Inc., a clinical-stage biopharmaceutical company, announced the pricing of an upsized underwritten public offering of 17.65 million shares at $17.00 per share, generating approximately $300 million in gross proceeds. The offering is expected to close on January 9, 2026, with underwriters granted a 30-day option to purchase an additional 2.65 million shares. Morgan Stanley, Leerink Partners, Cantor, and Wells Fargo Securities are serving as joint book-running managers.

ALMS - The company successfully priced an upsized public offering at $17.00 per share, raising $300 million to fund its clinical-stage drug development pipeline. The upsizing of the offering and strong pricing indicate investor confidence in the company's therapeutic candidates, particularly its lead program envudeucitinib for immune-mediated diseases.

#public offering #biopharmaceutical #clinical-stage #tyrosine kinase 2 inhibitors #envudeucitinib #immune-mediated diseases #capital raise

DeFi Technologies Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against DeFi Technologies Inc. - DEFT

GlobeNewswire Inc. • Claimsfiler

DeFi Technologies Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against DeFi Technologies Inc. - DEFT

01/07/2026 10:42 PM • DeFi Technologies Inc. faces a securities class action lawsuit for failing to disclose material information. The company announced a nearly 20% revenue decline and slashed its 2025 revenue forecast from $218.6 million to $116.6 million, citing delays in executing arbitrage opportunities. The stock fell 27.59% following the announcement. Investors with losses exceeding $100,000 have until January 30, 2026 to file lead plaintiff applications.

DEFT - The company faces securities litigation for failing to disclose material information, announced a 20% revenue decline, significantly reduced its full-year revenue guidance by approximately 47%, and experienced a sharp 27.59% stock price decline following the announcement.

#class action lawsuit #securities fraud #revenue decline #material information disclosure #stock price decline #lead plaintiff deadline

OBOOK Holdings Inc. (OWLS) to Adopt x402 Standard to Unlock AI Agent Revenue for Global Merchants

GlobeNewswire Inc. • Na

OBOOK Holdings Inc. (OWLS) to Adopt x402 Standard to Unlock AI Agent Revenue for Global Merchants

01/07/2026 10:37 PM • OwlTing announced integration with Coinbase's x402 ecosystem to provide merchant infrastructure for AI-initiated payments. The company's OwlPay Checkout solutions will enable businesses to receive and settle payments from AI agents in compliance with regulatory frameworks. OwlTing holds Money Transmitter Licenses in 39 U.S. states and multiple international licenses, positioning itself to capture the emerging agentic commerce market estimated at $1-5 trillion globally by 2030.

JPM - Participating as lead bank in the bridge loan syndicate without significant additional context
OWLS - Company is positioning itself as a critical infrastructure provider in the emerging agentic commerce market with strong regulatory credentials (39 U.S. state licenses), strategic partnership with Coinbase, and access to a market projected to reach $1-5 trillion globally. The integration addresses a key market gap and demonstrates business expansion into high-growth AI-driven commerce.

#agentic commerce #AI payments #x402 standard #OwlPay Checkout #fintech #payment infrastructure #regulatory compliance #digital currency

Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire Inc. • Na

Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants

01/07/2026 10:33 PM • Phathom Pharmaceuticals priced a $130 million underwritten public offering consisting of 6.875 million shares of common stock at $16.00 per share and 1.25 million pre-funded warrants at $15.999 per warrant. The offering is expected to close on January 9, 2026, with net proceeds intended for general corporate purposes including working capital, commercialization, and R&D expenses. Guggenheim Securities and Cantor are serving as joint bookrunning managers.

JPMpC - Participating as lead bank in the bridge loan syndicate without significant additional context
PHAT - The company successfully priced a substantial $130 million capital raise, demonstrating investor confidence and providing significant funding for commercialization and R&D activities. This capital infusion supports the company's growth strategy for its marketed GI disease treatments.

#public offering #capital raise #common stock #pre-funded warrants #biopharmaceutical #gastrointestinal diseases #vonoprazan #VOQUEZNA

F5 Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against F5, Inc. - FFIV

GlobeNewswire Inc. • Claimsfiler

F5 Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against F5, Inc. - FFIV

01/07/2026 10:32 PM • F5, Inc. faces a securities class action lawsuit for failing to disclose material information during October 2024 to October 2025. The company announced significantly below-market growth expectations for fiscal 2026, including reduced sales, elongated sales cycles, and increased expenses due to a security breach in BIG-IP. F5's stock price fell 10.9% following the announcement on October 28, 2025. Investors with losses exceeding $100,000 have until February 17, 2026 to file lead plaintiff applications.

JPMpD - Participating as lead bank in the bridge loan syndicate without significant additional context
FFIV - F5 faces securities litigation for failing to disclose material information, announced significantly below-market growth expectations, disclosed a security breach in its highest revenue product (BIG-IP), and experienced a 10.9% stock price decline following the announcement.

#securities class action #material information disclosure #security breach #BIG-IP #stock price decline #lead plaintiff deadline #fiscal 2026 guidance

Alexandria Real Estate Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Alexandria Real Estate Equities, Inc. - ARE

GlobeNewswire Inc. • Claimsfiler

Alexandria Real Estate Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Alexandria Real Estate Equities, Inc. - ARE

01/07/2026 10:31 PM • Alexandria Real Estate Equities (ARE) is facing a securities class action lawsuit for failing to disclose material information during the Class Period (January 27 - October 27, 2025). The company disclosed disappointing Q3 2025 results on October 27, 2025, including a $323.9 million real estate impairment charge, lower occupancy rates, and reduced FFO guidance. The stock plummeted 19% from $77.87 to $62.94 in a single day. Investors with losses exceeding $100,000 have until January 26, 2026 to file lead plaintiff applications.

JPMpJ - Participating as lead bank in the bridge loan syndicate without significant additional context
ARE - The company faces securities litigation for failing to disclose material negative information, experienced a significant 19% single-day stock decline following disappointing earnings results, a substantial $323.9 million impairment charge, lower occupancy rates, and reduced full-year guidance.

#securities class action #material non-disclosure #real estate impairment #stock decline #occupancy rates #FFO guidance cut #lead plaintiff deadline

Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock

GlobeNewswire Inc. • Na

Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock

01/07/2026 09:33 PM • Bright Minds Biosciences priced an upsized public offering of 1,945,000 common shares at $90 per share for gross proceeds of $175.05 million. The company plans to use net proceeds to fund clinical trials for drug candidates targeting absence seizures, DEE, and Prader-Willi Syndrome, as well as phase 1 trials for BMB-105. The offering is expected to close on January 9, 2026.

AGX - Company demonstrates strong financial health with low LTV ratios, high Interest Coverage Ratio, and a stable Investment Grade credit rating, indicating robust financial management and strategic planning for upcoming bond refinancing
DRUG - The company successfully upsized its public offering from $100 million to $175 million, demonstrating strong investor demand. The offering will fund advancement of clinical trials for multiple drug candidates, including BMB-101 which showed positive Phase 2 results with significant anti-seizure benefits. This capital raise supports pipeline expansion and R&D acceleration.

#public offering #common shares #clinical trials #epilepsy #BMB-101 #BMB-105 #biotechnology #fundraising

NGG Investor News: If You Have Suffered Losses in National Grid plc (NYSE: NGG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire Inc. • The Rosen Law Firm

NGG Investor News: If You Have Suffered Losses in National Grid plc (NYSE: NGG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

01/07/2026 07:49 PM • The Rosen Law Firm is investigating potential securities claims against National Grid plc following allegations of materially misleading business information. The investigation was triggered by a July 2025 Reuters report revealing that National Grid failed to maintain an electricity substation that caused a fire at London's Heathrow Airport in March 2025, despite the issue being identified seven years prior. National Grid's ADSs fell 5% following the news disclosure.

CRARY - Participating as part of the banking pool in a standard loan syndication
NGG - The company is facing securities litigation for allegedly issuing materially misleading information. A preventable infrastructure failure caused significant disruption (airport closure), and the underlying issue was known for seven years but not addressed, indicating potential negligence and mismanagement that could result in financial penalties and reputational damage.

#securities fraud #class action lawsuit #National Grid #Heathrow Airport fire #investor losses #misleading disclosures

STUB INVESTOR ALERT: Hagens Berman Notifies StubHub Holdings, Inc. (STUB) Investors of Jan. 23 Deadline in IPO Securities Class Action Investigation

GlobeNewswire Inc. • Hagens Berman

STUB INVESTOR ALERT: Hagens Berman Notifies StubHub Holdings, Inc. (STUB) Investors of Jan. 23 Deadline in IPO Securities Class Action Investigation

01/07/2026 06:48 PM • Hagens Berman is investigating StubHub Holdings (STUB) for allegedly failing to disclose critical vendor payment timing issues in its September 2025 IPO documents. The company reported a 143% collapse in free cash flow in its first quarterly results, causing the stock to plummet over 20% in a single day and trade 56% below its $23.50 IPO price. The lead plaintiff deadline is January 23, 2026.

JPMpJ - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
STUB - Company faces securities class action lawsuit for allegedly misleading IPO disclosures regarding vendor payment timing issues. Free cash flow collapsed 143%, stock dropped 56% below IPO price, and significant investor losses reported.

#securities class action #IPO disclosure #free cash flow decline #vendor payments #stock price collapse #lead plaintiff deadline

F5, Inc. (FFIV) Cybersecurity Incident-Related Securities Class Action Pending As Adverse Financial Impact Clarified – Hagens Berman

GlobeNewswire Inc. • Hagens Berman

F5, Inc. (FFIV) Cybersecurity Incident-Related Securities Class Action Pending As Adverse Financial Impact Clarified – Hagens Berman

01/07/2026 06:35 PM • F5, Inc. faces a securities class action lawsuit following disclosure of a material cybersecurity breach discovered on August 9, 2025. The company's BIG-IP source code was compromised by a sophisticated threat actor with persistent access. F5's delayed disclosure and subsequent revelation of significantly reduced 2026 revenue guidance (0-4% growth vs. 10% in 2025) triggered sharp stock declines of 10% and 7% on announcement dates. The lawsuit questions whether management knew about the breach's materiality before public disclosure.

JPMpK - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
FFIV - F5 experienced a material cybersecurity breach with persistent unauthorized access to its engineering platforms and BIG-IP source code. The company faces a securities class action lawsuit alleging misleading disclosures and delayed reporting. Stock prices declined sharply (10% and 7%) following breach announcements, and 2026 revenue guidance was significantly reduced to 0-4% growth, well below analyst expectations, indicating substantial operational and financial impact.

#cybersecurity breach #BIG-IP source code #securities class action #disclosure timing #revenue guidance #stock decline #nation-state threat actor

OceanFirst Financial Corp. Schedules Earnings Conference Call

GlobeNewswire Inc. • Na

OceanFirst Financial Corp. Schedules Earnings Conference Call

01/07/2026 06:34 PM • OceanFirst Financial Corp. announced it will release its Q4 2025 earnings on January 22, 2026, followed by a management conference call on January 23, 2026. The company, a $14.3 billion regional bank headquartered in New Jersey, will discuss quarterly operating performance with investors.

JPMpL - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
OCFC - The article is a routine announcement of earnings release and conference call dates with no material business updates, financial performance indicators, or strategic developments disclosed. It is procedural in nature and contains standard forward-looking statement disclaimers.

#earnings release #conference call #Q4 2025 #regional bank #New Jersey #financial services

Aveanna Insider Sells $292,000 in Stock as Shares Surge 99% -- Here's What Long-Term Investors Should Know

The Motley Fool • Jonathan Ponciano

Aveanna Insider Sells $292,000 in Stock as Shares Surge 99% -- Here's What Long-Term Investors Should Know

01/07/2026 06:33 PM • Patrick Cunningham, chief compliance officer of Aveanna Healthcare, sold 36,015 shares worth $292,488 between December 30 and January 2. The sale represented 10.93% of his direct holdings but was driven by tax obligations from vested equity awards rather than discretionary selling. Despite the insider sale, the company is experiencing strong operational momentum with Q3 revenue up 22.2% and adjusted EBITDA surging 67.5%, with shares up 99% over the past year.

JPMpM - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
AVAH - Despite insider selling, the company demonstrates strong fundamentals with Q3 revenue growth of 22.2% YoY, adjusted EBITDA surge of 67.5%, raised full-year guidance, and stock appreciation of 99% over the past year. The insider sale was driven by tax obligations rather than discretionary selling, and the article emphasizes that operational momentum is more consequential than the stock sale for long-term investors.

#insider selling #stock sale #home healthcare #revenue growth #EBITDA expansion #equity awards #tax obligations

Why Alphabet Stock Topped the Market Today

The Motley Fool • Eric Volkman

Why Alphabet Stock Topped the Market Today

01/07/2026 06:31 PM • Alphabet's stock rose over 2% following news that U.S. lawmakers will hold hearings on advancing autonomous vehicle technology. The House energy and commerce subcommittee will consider proposals to increase self-driving vehicle deployments, including allowing up to 90,000 autonomous vehicles per year. This development is positive for Alphabet's Waymo subsidiary, a leader in self-driving technology, which has high-level political and administrative support.

VYLD - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
GOOG - Stock gained 2.5% on news of congressional hearings supporting autonomous vehicle advancement. Alphabet's Waymo subsidiary is positioned as a leader in self-driving technology with high-level political backing from both lawmakers and the Trump administration, suggesting favorable regulatory conditions ahead.

#autonomous vehicles #self-driving technology #Waymo #regulatory framework #political support #vehicle deployment

FCX: Kirby McInerney LLP Advises Freeport-McMoran Inc. Investors of Class Action Lawsuit

GlobeNewswire Inc. • Kirby Mcinerney Llp

FCX: Kirby McInerney LLP Advises Freeport-McMoran Inc. Investors of Class Action Lawsuit

01/07/2026 06:00 PM • A securities fraud class action lawsuit has been filed against Freeport-McMoRan Inc. for allegedly failing to ensure adequate safety at its Grasberg Block Cave mine in Indonesia. The lawsuit covers investors who purchased securities between February 15, 2022 and September 24, 2025. On September 9, 2025, Freeport announced suspension of mining operations after seven workers became trapped, causing the stock to decline 5.94% ($2.77 per share). The lawsuit alleges the company failed to disclose heightened regulatory, litigation, and reputational risks.

BMLpL - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
FCX - The company faces a securities fraud class action lawsuit alleging inadequate safety measures at a major mining operation, resulting in worker entrapment and mine suspension. The incident triggered a significant stock price decline of 5.94%, and the lawsuit alleges undisclosed regulatory, litigation, and reputational risks.

#securities fraud #class action lawsuit #mining safety #Grasberg Block Cave #Indonesia #worker safety #stock decline #regulatory risk

BTDR Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Bitdeer Technologies Group (BTDR) Shareholders of Deadline in Securities Fraud Class Action Lawsuit

GlobeNewswire Inc. • Kessler Topaz Meltzer & Check, Llp

BTDR Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Bitdeer Technologies Group (BTDR) Shareholders of Deadline in Securities Fraud Class Action Lawsuit

01/07/2026 06:00 PM • A securities class action lawsuit has been filed against Bitdeer Technologies Group (NASDAQ: BTDR) for allegedly making materially false and misleading statements regarding its SEAL04 chip design progress and production timeline. The complaint alleges that Bitdeer concealed delays and design issues while reassuring the public that operations remained on track. The lead plaintiff deadline is February 2, 2026.

BMLpJ - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
BTDR - The company is the subject of a securities fraud class action lawsuit alleging material misstatements and omissions regarding chip design delays and production timelines. Shareholders who purchased securities during the class period (June 6, 2024 - November 10, 2025) are eligible to seek damages, indicating significant corporate misconduct and investor harm.

#securities fraud #class action lawsuit #SEAL04 chip #material misstatement #lead plaintiff #BTDR #Bitdeer Technologies Group

Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman

GlobeNewswire Inc. • Hagens Berman

Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman

01/07/2026 05:58 PM • Corcept Therapeutics (CORT) shares plummeted 50% on December 31, 2025, after the company received an FDA Complete Response Letter for relacorilant, indicating the FDA requires additional evidence of effectiveness for the hypercortisolism treatment. The sharp decline wiped out $3.6 billion in market capitalization, prompting a shareholder rights investigation into whether the company misled investors about the drug's efficacy and commercial prospects.

MERpK - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
CORT - The company received an FDA Complete Response Letter rejecting its drug application, resulting in a 50% stock price decline and $3.6 billion market cap loss. The investigation suggests potential investor misrepresentation regarding drug efficacy and commercial growth prospects.

#FDA Complete Response Letter #relacorilant #hypercortisolism #Cushing's syndrome #drug approval #shareholder investigation #stock decline #investor losses

Vornado Acquires 3 East 54th Street, a Premier Plaza District Development Site

Benzinga • Globe Newswire

Vornado Acquires 3 East 54th Street, a Premier Plaza District Development Site

01/07/2026 05:57 PM • Vornado Realty Trust (NYSE:VNO) announced the acquisition of 3 East 54th Street in Manhattan's Plaza District for $141 million. The 18,400 square-foot demolition-ready site, located between Fifth and Madison Avenues near the St. Regis Hotel, is zoned for approximately 232,500 buildable square feet. Vornado acquired the property's mortgage in 2024-2025, with the $107 million loan balance credited toward the purchase price. The acquisition complements Vornado's existing nearby holdings in the Plaza District and Park Avenue.

VRSN - Berkshire sold 32% of shares to maintain ownership below 10%, with the sale aligned with previously announced intentions
VNO - The acquisition of a prime Manhattan development site in a prestigious location (Plaza District between Fifth and Madison Avenues) with significant buildable square footage (232,500 sq ft) represents strategic expansion of Vornado's high-value real estate portfolio. The favorable financing structure, where the existing mortgage was credited toward the purchase price, demonstrates operational efficiency and value creation for the company.

#real estate acquisition #Manhattan development #Plaza District #commercial real estate #REIT #property development

GlobeNewswire Inc. • Na

Vornado Acquires 3 East 54th Street, a Premier Plaza District Development Site

01/07/2026 05:57 PM • Vornado Realty Trust announced the acquisition of 3 East 54th Street, a demolition-ready property on 18,400 square feet of land in Manhattan, for $141 million. The company acquired the mortgage on the property in 2024-2025 with a loan balance of $107 million, which was credited toward the purchase price. The site is zoned for approximately 232,500 buildable square feet and complements Vornado's existing Park Avenue and Fifth Avenue holdings.

VNO - The acquisition of a prime Manhattan property in a strategic location adjacent to the St. Regis Hotel and complementing existing high-value holdings demonstrates active portfolio expansion and development opportunities. The company's ability to convert a mortgage into an acquisition with significant buildable square feet (232,500 sq ft) indicates strong strategic positioning and growth potential in a premium real estate market.

#real estate acquisition #Manhattan property #demolition-ready asset #Upper Fifth Avenue #development opportunity #REIT

QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

GlobeNewswire Inc. • Kessler Topaz Meltzer & Check, Llp

QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

01/07/2026 05:56 PM • Law firm Kessler Topaz Meltzer & Check is investigating potential securities law violations by uniQure N.V. after the FDA rejected sufficient evidence for the company's AMT-130 gene therapy BLA submission on November 3, 2025. The announcement caused uniQure's stock to plummet over 50%, falling from $67.69 to $34.29. The firm is encouraging affected investors to contact them regarding the potential class action lawsuit.

JPM - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
QURE - FDA rejected sufficient evidence for AMT-130 BLA submission, causing stock to fall over 50% in a single day. The company faces regulatory setback, unclear timeline for product approval, and potential securities litigation.

#securities fraud #FDA rejection #gene therapy #class action lawsuit #stock price decline #BLA submission #Huntington's disease

LRN 5-DAY DEADLINE ALERT: Stride (LRN) Investors Encouraged to Contact Hagens Berman, Securities Class Action Pending Over Alleged Undisclosed Operational Failures

GlobeNewswire Inc. • Hagens Berman

LRN 5-DAY DEADLINE ALERT: Stride (LRN) Investors Encouraged to Contact Hagens Berman, Securities Class Action Pending Over Alleged Undisclosed Operational Failures

01/07/2026 05:51 PM • Hagens Berman has filed a securities class action lawsuit against Stride, Inc. (LRN) alleging the company inflated enrollment figures using 'Ghost Students' and concealed a catastrophic technology platform failure. The undisclosed operational failures led to a 54% single-day stock crash, with the company forced to slash growth forecasts from 19% to 5%. The lead plaintiff deadline is January 12, 2026.

JPMpC - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
LRN - The company is accused of systematic fraud involving inflated enrollment metrics, concealment of known technology failures, and misleading investors about operational stability. These allegations resulted in a 54% stock crash and billions in market capitalization loss, indicating severe reputational and financial damage.

#securities fraud #class action lawsuit #enrollment inflation #Ghost Students #technology platform failure #stock crash #operational failures #misrepresentation